Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Some remain comfortable with weekly injections despite needle requirements
Product Category Once-weekly injectable GLP-1 receptor agonist for type 2 diabetes and weight management Generic Name or Biosimilar Semaglutide (no biosimilars currently available) Active Ingredient Semaglutide Prescription Status Prescription-only (Rx) Targeted Conditions Type 2 diabetes in adults (to improve blood sugar control) To reduce risk of major cardiovascular events in adults with type 2 diabetes and known heart disease Weight loss and obesity management (off-label) Ozempic is a powerful option for patients needing glucose control, cardiovascular risk reduction, and for those who may benefit from significant weight loss
Oct 2015;14(5):887-95
For patients pursuing integrative wellness protocols, DSIP may be considered alongside other evidence-informed approaches such as NAD+ therapy, peptide support, and IV nutritional therapy
Will be refilling
